{
    "Trade/Device Name(s)": [
        "IMMULITE\u00ae 2500 High Sensitivity C-Reactive Protein Immunoassay"
    ],
    "Submitter Information": "Siemens Medical Solutions Diagnostics",
    "510(k) Number": "K071017",
    "Predicate Device Reference 510(k) Number(s)": [
        "K063057",
        "K003372"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NQD"
    ],
    "Summary Letter Date": "May 2, 2007",
    "Summary Letter Received Date": "April 10, 2007",
    "Submission Date": "April 6, 2007",
    "Regulation Number(s)": [
        "21 CFR 866.5270"
    ],
    "Regulation Name(s)": [
        "C-reactive protein immunological test system"
    ],
    "Analyte Class(es)": [
        "immunology"
    ],
    "Analyte(s)": [
        "C-reactive protein"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "IMMULITE 2500 Automated Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Solid-phase immunometric assay",
        "Chemiluminescent immunoassay"
    ],
    "Methodologies": [
        "Immunometric assay",
        "Chemiluminescent detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for IMMULITE 2500 High Sensitivity C-Reactive Protein Immunoassay for quantitative CRP measurement using chemiluminescent immunoassay on the IMMULITE 2500 analyzer.",
    "Indications for Use Summary": "For in vitro diagnostic use with the IMMULITE 2500 analyzer for quantitative measurement of C-reactive protein in serum or plasma as an aid in detecting infection, tissue injury, inflammatory disorders, and identifying individuals at risk for cardiovascular disease.",
    "fda_folder": "Immunology"
}